TEX13A Activators
Activation of TEX13A involves a complex interplay of signaling pathways and phosphorylation events that can be influenced by various small molecules. Compounds that elevate cAMP levels in cells, for instance, exert their effect by stimulating adenylyl cyclase or inhibiting phosphodiesterases, leading to the activation of PKA. Once activated, PKA may phosphorylate TEX13A directly or target proteins that modulate TEX13A's activity. This cascade is further supported by cAMP analogs and beta-adrenergic agonists that mimic the effects of endogenous signaling molecules, enhancing the PKA-mediated phosphorylation of TEX13A. Moreover, the activation of PKC through different agents can also lead to phosphorylation events that ultimately increase the activity of TEX13A, assuming it is a substrate for PKC or is regulated by PKC-dependent pathways. Similarly, agents that induce an influx of calcium ions into the cell can activate calcium-dependent kinases, which may then facilitate the phosphorylation and activation of TEX13A.
Aside from kinase activation, other mechanisms also play a pivotal role in modulating TEX13A activity. For example, the inhibition of GSK-3 by certain compounds leads to the activation of the Wnt signaling pathway, which could indirectly enhance TEX13A activity through the modulation of downstream targets within the pathway. The use of nitric oxide donors can increase cGMP levels, potentially influencing pathways that activate TEX13A. Furthermore, the activation of AMPK by specific activators can affect cellular energy balance, which might indirectly modulate TEX13A activity by altering energy-sensitive cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels in cells. Elevated cAMP is known to activate PKA, which could phosphorylate and thus increase the activity of TEX13A through downstream signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which is involved in serine/threonine phosphorylation. PKC-mediated phosphorylation may enhance TEX13A activity if TEX13A is a substrate or is regulated by PKC-dependent pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases, which prevents cAMP degradation, thus potentially enhancing TEX13A activity through PKA signaling pathways that are cAMP-dependent. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels by forming complexes with calcium ions and transporting them across membranes, potentially activating calcium-dependent kinases that could phosphorylate and thereby activate TEX13A. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that increases intracellular calcium, potentially activating calmodulin-dependent kinases or other calcium-sensitive pathways that could lead to TEX13A activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that increases cAMP levels, potentially leading to activation of TEX13A through PKA-dependent signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, leading to activation of the Wnt signaling pathway. Activation of downstream targets of Wnt signaling may indirectly increase TEX13A activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that activates PKA, potentially enhancing TEX13A activity through phosphorylation events mediated by PKA. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective inhibitor of phosphodiesterase 4, which leads to increased cAMP levels, potentially enhancing TEX13A activity via PKA-dependent signaling pathways. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
Activates AMP-activated protein kinase (AMPK), which can influence cellular energy homeostasis and potentially affect TEX13A activity through regulation of energy-sensitive pathways. | ||||||